Squarepoint Ops LLC Compass Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.0 - $1.85 $13,321 - $24,643	13,321 Added 26.22%	64,133 $64,000
Q1 2024 May 15, 2024	SELL	$1.2 - $2.29 $45,489 - $86,809	-37,908 Reduced 42.73%	50,812 $100,000
Q4 2023 Feb 14, 2024	BUY	$1.4 - $1.98 $124,207 - $175,665	88,720 New	88,720 $138,000
Q1 2023 May 15, 2023	BUY	$3.14 - $5.48 $51,065 - $89,121	16,263 New	16,263 $53,000

92M

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $161M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.